Process for preparing the calcium salt of rosuvastatin

Details Process for preparing the calcium salt of rosuvastatin Process for preparing the calcium salt of rosuvastatin

2009-02-13

2010-11-30

Balasubramanian, Venkataraman (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

C544S330000, C544S332000, C514S275000

Reexamination Certificate

active

07842807

ABSTRACT:
An improved process for manufacture of (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid calcium salt, which is useful for the production of a pharmaceutical useful in the treatment of, inter alia, hypercholesterolemia, hyperlipoproteinemia and atherosclerosis, is described.

REFERENCES:
patent: 4645858 (1987-02-01), Lowrie et al.
patent: 4970313 (1990-11-01), Wess et al.
patent: 4977279 (1990-12-01), Wess et al.
patent: 5026698 (1991-06-01), Fujikawa et al.
patent: 5260440 (1993-11-01), Hirai et al.
patent: 5278313 (1994-01-01), Thottathil et al.
patent: 5399722 (1995-03-01), Beck et al.
patent: 5594153 (1997-01-01), Thottathil et al.
patent: 6278001 (2001-08-01), Solladie et al.
patent: 6331641 (2001-12-01), Taoka et al.
patent: 6784171 (2004-08-01), Taylor et al.
patent: 6844437 (2005-01-01), Taylor et al.
patent: 6870059 (2005-03-01), Kooistra et al.
patent: 6875867 (2005-04-01), Brodfuehrer et al.
patent: 7157255 (2007-01-01), Blacker et al.
patent: 7304156 (2007-12-01), Matsushita et al.
patent: 7416865 (2008-08-01), Blacker et al.
patent: 7442811 (2008-10-01), Bakel Van et al.
patent: 7511140 (2009-03-01), Horbury et al.
patent: 7524955 (2009-04-01), Newton et al.
patent: 7642363 (2010-01-01), Kooistra et al.
patent: 2003/0018199 (2003-01-01), Brodfuehrer et al.
patent: 2003/0114685 (2003-06-01), Niddam-Hildesheim et al.
patent: 2005/0090674 (2005-04-01), Hof
patent: 2005/0124639 (2005-06-01), Joshi et al.
patent: 2005/0209259 (2005-09-01), Huang
patent: 2006/0004200 (2006-01-01), Gudipati et al.
patent: 2006/0293355 (2006-12-01), Booth et al.
patent: 2007/0105882 (2007-05-01), Black et al.
patent: 2007/0255060 (2007-11-01), Okada et al.
patent: 2008/0058520 (2008-03-01), Matsushita et al.
patent: 2008/0188657 (2008-08-01), Lenger
patent: 2008/0207903 (2008-08-01), Butters et al.
patent: 2008/0221323 (2008-09-01), Crabb et al.
patent: 2008/0280336 (2008-11-01), Blacker et al.
patent: 2009/0264654 (2009-10-01), Newton et al.
patent: 2009/0286819 (2009-11-01), Horbury et al.
patent: 2545316 (2005-05-01), None
patent: 0521471 (2000-10-01), None
patent: WO 90/03973 (1990-04-01), None
patent: WO 93/08823 (1993-05-01), None
patent: WO 97/03959 (1997-02-01), None
patent: WO 97/19917 (1997-06-01), None
patent: WO 97/49681 (1997-12-01), None
patent: WO 00/42024 (2000-07-01), None
patent: WO 00/49014 (2000-08-01), None
patent: WO 01/22962 (2001-04-01), None
patent: WO 01/36384 (2001-05-01), None
patent: WO 01/54669 (2001-08-01), None
patent: WO 01/60804 (2001-08-01), None
patent: WO 01/72706 (2001-10-01), None
patent: WO 01/85702 (2001-11-01), None
patent: WO 01/85975 (2001-11-01), None
patent: WO 02/06266 (2002-01-01), None
patent: WO 02/30415 (2002-04-01), None
patent: WO 02/43667 (2002-06-01), None
patent: WO 02/43732 (2002-06-01), None
patent: WO 02/072566 (2002-09-01), None
patent: WO 02/083637 (2002-10-01), None
patent: WO 02/098854 (2002-12-01), None
patent: WO 03/006439 (2003-01-01), None
patent: WO 03/016317 (2003-02-01), None
patent: WO 03/018555 (2003-03-01), None
patent: WO 03/026573 (2003-04-01), None
patent: WO 03/059901 (2003-07-01), None
patent: WO 03/087112 (2003-10-01), None
patent: WO 03/097614 (2003-11-01), None
patent: WO 03/106447 (2003-12-01), None
patent: WO 2004/014872 (2004-02-01), None
patent: WO 2004/052867 (2004-06-01), None
patent: WO 2004/054986 (2004-07-01), None
patent: WO 2004/089895 (2004-10-01), None
patent: WO 2004/103977 (2004-12-01), None
patent: WO 2004/108691 (2004-12-01), None
patent: WO 2005/005384 (2005-01-01), None
patent: WO 2005/023778 (2005-03-01), None
patent: WO 2005/023779 (2005-03-01), None
patent: WO 2005/028450 (2005-03-01), None
patent: WO 2005/030215 (2005-04-01), None
patent: WO 2005/040134 (2005-05-01), None
patent: WO 2005/042522 (2005-05-01), None
patent: WO 2005/047276 (2005-05-01), None
patent: WO 2005/051921 (2005-06-01), None
patent: WO 2005/054207 (2005-06-01), None
patent: WO 2005/056534 (2005-06-01), None
patent: WO 2005/063728 (2005-07-01), None
patent: WO 2005/068435 (2005-07-01), None
patent: WO 2005/077916 (2005-08-01), None
patent: WO 2005/077917 (2005-08-01), None
patent: WO 2005/092867 (2005-10-01), None
patent: WO 2006/017357 (2006-02-01), None
patent: WO 2006/035277 (2006-04-01), None
patent: WO 2006/067456 (2006-06-01), None
patent: WO 2006/079611 (2006-08-01), None
patent: WO 2006/089401 (2006-08-01), None
patent: WO 2007/007119 (2007-01-01), None
Hiyama et al. “Synthesis of Artificial HMG-CoA Reductase Inhibitors Based on the Olefination Strategy” Bull. Chem. Soc. Jpn. 68 (1):364-372 (1995).
Kaneko et al. “Preparation of optically active 5,6-epoxyhexanoic acid esters as materials for physiologically active substances” Chemical Abstracts + Indexes, American Chemical Society, Columbus, US 118(11):832 (1993).
Menges et al. “Oxidative Degradation of γ-Butyrolactons into 1,3-Diols via a Criegee Rearrangement of Peroxosulfonates. An Enantioselective Synthesis of Compactin Lactone and its Diastereomer” Synlett 12:901-905 (1993).
Minami et al. “A Novel Enantioselective Synthesis of HMG Co-A Reductase Inhibitor NK-104 and a Related Compound” Tetrahedron letters 33(49):7525-7526 (1992).
Minami et al. “Stereoselective Reduction of β,-Diketo Esters Derived From Tartaric Acid. A Facile Route to Optically Active 6-oxo-3,5-syn-isopropylidenedioxyhexanoate, a Versatile Synthetic Intermediate of Artificial HMG Co-A Reductase Inhibitors” Tetrahedron Letters 34(3):513-516 (1993).
Moore et al. “Biosynthesis of the hypocholesterolemic agent mevinolin by Aspergillus terreus. Determination of the origin of carbon, hydrogen, and oxygen atoms by carbon-13 NMR and mass spectrometry” J. Am. Chem. Soc. 107(12): 3694-3701 (1985).
Nezasa et al. “Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat” Xenobiotica 32(8):715-727 (2002).
Prasad et al. “A novel diastereroselective synthesis of lactone moiety of compactin” Tetrahedron Letters 25(23):2435-2438 (1984).
Presentation given at the 20th International Congress of Heterocyclic Chemistry in Palermo, Aug. 1-5, 2005.
Presentation given at the Gordon Conference on Heterocyclic Compounds, Salve Regina University, Newport, Rhode Island, Jul. 4-9, 2004.
Sakaki et al. “Lipase-catalyzed asymmetric synthesis of 6-(3-chloro-2-hydroxypropyl)-1,3-dioxin-4-ones and their conversion to chiral 5,6-epoxyhexanoates” Tetrahedron: Asymmetry 2(5):343-346 (1991).
Shao et al. “Asymmetric hydrogenation of 3,5-Dioxoesters catalyzed by Ru-binap complex: A short step asymmetric synthesis of 6-substituted 5,6-dihydro-2-pyrones” Tetrahedron 49(10):1997-2010 (1993).
Solladié et al. “Chrial Sulfoxides in Asymmetric Synthesis: Enantioselective Synthesis of the Lactonic Moiety of (+)-Compactin and (+)-Mevinolin. Application of a Compactin Analogue” J. Org. Chem. 60:7774-7777 (1995).
Watanabe et al. “Synthesis and Biological Activity of Methanesulfonamide Pyrimidine- and N-Methanesulfonyl Pyrrole-Substituted 3,5-Dihydroxy-6-heptenoates, a Novel Series of HMG-CoA Reductase Inhibitors” Bioorganic & Medicinal Chemistry 5(2):437-444 (1997).
Wess et al. “Stereoselective Synthesis of HR 780 A New Highly Potent HMG-CoA Reductase Inhibitor”, Tetrahedron Letters 31(18): 2545-2548 (1990).

Affiliated with

Also associated with

Rating

Process for preparing the calcium salt of rosuvastatin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for preparing the calcium salt of rosuvastatin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing the calcium salt of rosuvastatin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4251377